Lexicon Pharmaceuticals
LXRX
#7142
Rank
$0.50 B
Marketcap
$1.40
Share price
-1.41%
Change (1 day)
97.18%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -$0.19

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$0.19. In 2024 the company made an earnings per share (EPS) of -$0.64 an increase over its 2023 EPS that were of -$0.80.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$0.19-70.31%
2024-$0.64-20%
2023-$0.8031.15%
2022-$0.61-0%
2021-$0.6110.91%
2020-$0.55-145.08%
2019$1.22-206.09%
2018-$1.15-5.74%
2017-$1.22-10.95%
2016-$1.372640%
2015-$0.05000-96.34%
2014-$1.36-2.53%
2013-$1.40-9.09%
2012-$1.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eterna Therapeutics
ERNA
-$76.71 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$43.44-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-$5.94 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$2.72-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$17.34-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-$0.54 184.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$4.47-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$2.39-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-$0.75 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA